Cigna

Does Cigna cover Mounjaro?

Quick answer · Type 2 Diabetes

Cigna covers Mounjaro for type 2 diabetes with prior authorization on Employer / Commercial Insurance, Medicare Part D, Medicare Advantage, and ACA Marketplace.

  • Employer / Commercial Insurance: Covered with requirements. Age 10 and older
  • Medicare Part D: Covered with requirements. No additional clinical requirements listed.
  • Medicare Advantage: Covered with requirements. No additional clinical requirements listed.
  • ACA Marketplace: Covered with requirements. Age 10 and older

Last verified June 11, 2026. Policy effective July 1, 2026. Source: cnf_360_coveragepositioncriteria_glucagon-like_peptide-1_agonists_pa.pdf and prior-authorization-crosswalked.pdf. How we verify this data →

Check your card for your exact plan →

Mounjaro for Type 2 Diabetes

What Cigna requires, by plan type. Open this indication on its own page →

Employer / Commercial Insurance

Covered with requirements

What you need to qualify

  • Age 10 and older

Qualification pathways

You can qualify through any one of these.

Type 2 Diabetes Mellitus – age-based approval

All of:

  • Diagnosis of type 2 diabetes mellitus
  • Patient is >= 10 years of age

Documentation to bring

  • Documentation of type 2 diabetes mellitus diagnosis
  • Patient age >= 10 years

Approval and renewal

  • Initial approval: 12 months

Not covered when

  • Weight loss without type 2 diabetes diagnosis
  • Prediabetes/diabetes prevention
  • Metabolic syndrome without type 2 diabetes
  • Concomitant use with other GLP-1 agonists or GLP-1/GIP agonists
  • Type 1 diabetes

Policy note: Automation exists: a Mounjaro claim will auto-adjudicate if the patient meets the lookback for one oral medication for diabetes (not including Rybelsus or single-entity metformin) and patient is >= 10 years of age (updated from >= 18 years of age effective 01/07/2026). If either condition is not met, full PA criteria apply. Zepbound (tirzepatide) is not included in this policy as it is not indicated for diabetes.

Policy effective May 6, 2026 · verified June 2, 2026 · source: cnf_360_coveragepositioncriteria_glucagon-like_peptide-1_agonists_pa.pdf

Medicare Part D

Covered with requirements

No additional clinical requirements are listed beyond the diagnosis.

Qualification pathways

You can qualify through any one of these.

All FDA-approved indications with diagnosis

All of:

  • Diagnosis documented
  • FDA-approved indication

Documentation to bring

  • Diagnosis documentation

Approval and renewal

  • Initial approval: 12 months

Policy note: Policy allows all FDA-approved indications with no prerequisite therapy required. Only required medical information is a diagnosis. No prescriber restrictions, no age restrictions, no exclusion criteria listed. Authorization duration is 1 year. No Part B prerequisite.

Policy effective July 1, 2026 · verified June 11, 2026 · source: prior-authorization-crosswalked.pdf

Medicare Advantage

Covered with requirements

No additional clinical requirements are listed beyond the diagnosis.

Qualification pathways

You can qualify through any one of these.

All FDA-approved indications with diagnosis

All of:

  • Diagnosis documented
  • FDA-approved indication

Documentation to bring

  • Diagnosis documentation

Approval and renewal

  • Initial approval: 12 months

Policy note: Policy allows all FDA-approved indications with no prerequisite therapy required. Only required medical information is a diagnosis. No prescriber restrictions, no age restrictions, no exclusion criteria listed. Authorization duration is 1 year. No Part B prerequisite.

Policy effective July 1, 2026 · verified June 11, 2026 · source: prior-authorization-crosswalked.pdf

ACA Marketplace

Covered with requirements

What you need to qualify

  • Age 10 and older

Qualification pathways

You can qualify through any one of these.

Type 2 Diabetes Mellitus – age-based approval

All of:

  • Diagnosis of type 2 diabetes mellitus
  • Patient is >= 10 years of age

Documentation to bring

  • Documentation of type 2 diabetes mellitus diagnosis
  • Patient age >= 10 years

Approval and renewal

  • Initial approval: 12 months

Not covered when

  • Weight loss without type 2 diabetes diagnosis
  • Prediabetes/diabetes prevention
  • Metabolic syndrome without type 2 diabetes
  • Concomitant use with other GLP-1 agonists or GLP-1/GIP agonists
  • Type 1 diabetes

Policy note: Automation exists: a Mounjaro claim will auto-adjudicate if the patient meets the lookback for one oral medication for diabetes (not including Rybelsus or single-entity metformin) and patient is >= 10 years of age (updated from >= 18 years of age effective 01/07/2026). If either condition is not met, full PA criteria apply. Zepbound (tirzepatide) is not included in this policy as it is not indicated for diabetes.

Policy effective May 6, 2026 · verified June 2, 2026 · source: cnf_360_coveragepositioncriteria_glucagon-like_peptide-1_agonists_pa.pdf

Why Mounjaro requests get denied by Cigna

Based on what this policy asks for. Fix these before the first submission.

  1. Wrong brand for the diagnosis. Mounjaro and Zepbound are the same molecule with different approved uses; a request for Mounjaro under a diagnosis that matches Zepbound is routinely denied.

Frequently asked questions

Does Cigna cover Mounjaro?
Cigna covers Mounjaro for type 2 diabetes with prior authorization on Employer / Commercial Insurance, Medicare Part D, Medicare Advantage, and ACA Marketplace.
How long does a Mounjaro approval last with Cigna?
Initial approvals last 12 months.
How current is this information?
This page reflects Cigna's written policy as of July 1, 2026, last verified against the source document on June 11, 2026.

Other medications under Cigna

Mounjaro coverage under other plans

All insurance plans · All medications

This page summarizes Cigna's written prior-authorization policy. It is not a guarantee of coverage; plans vary by employer and benefit design. Verify with your plan before relying on it.